C
Cardiol Therapeutics Inc. (CRDL)
NCM – Real Time Price. Currency in USD
1.04
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.08
+0.04 (3.85%)
After-hours: Jun 26, 2026, 4:45 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.04
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.08
+0.04 (3.85%)
After-hours: Jun 26, 2026, 4:45 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.39 | 2.52 | 10 | |
| Quick ratio | 4.39 | 1.78 | 10 | |
| Debt to Equity | 0.00 | -0.80 | 10 | |
| Debt to Assets | 0.00 | 0.73 | 10 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -162K | -187K | -259K | -74K | -75K |
| Operating Income | -30M | -22M | -28M | -25M | -26M |
| Net Income | -23M | -21M | -25M | -25M | -26M |
| EBITDA | -30M | -22M | -28M | -25M | -26M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 7.35 | 3.0 |
| Next quarter | N/A | 15.57 | 5.0 |
| Current year | N/A | -17.5 | 1.0 |
| Next year | N/A | 52.53 | 5.5 |
| Weighted average score | 3.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -48.07 | -41.03 | -42.84 | 3.3 |
| Y/Y | 999 | -35.05 | -3.46 | -9.22 | 3.3 |
| 3y average | 999 | -3.23 | 7.09 | 4.71 | 5.0 |
| 5y average | 779.2 | -11.05 | 10.42 | -30.23 | 4.8 |
| Weighted average score | 4.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $19.9M significantly exceed its total debt $83.7K, ensuring strong financial flexibility
Total current assets $22.5M exceed Total current liabilities $5.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$5.4M limits the company's ability to reinvest or pay down debt